Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Current Debt

Current Debt at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$1.03B+3,224%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$70M—
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$6.2M-80.5%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$1.24M-31.2%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$10.13M+537%
Alkermes logo
AlkermesALKS
——

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s current debt?
Harmony Biosciences Holdings, Inc. (HRMY) reported current debt of $20M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s current debt changed year-over-year?
Harmony Biosciences Holdings, Inc.'s current debt increased by 14.3% year-over-year, from $17.5M to $20M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s current debt?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s current debt has grown at a 77.8% compound annual growth rate (CAGR), from $2M to $20M.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.